Market Tracker

07/23 12:02pm ET
2.58
Real-Time Quote
 -0.01 / -0.39%
Today’s Change
1.20
Today|||52-Week Range
7.36
-42.39%
Year-to-Date
GERN Spin-Off of Shares: A share spin-off from a subsidiary occurred on 07/22/14 to GERN shareholders of record as of 05/28/14.

Today’s Trading

Previous close2.59
Today’s open2.60
Day’s range2.57 - 2.64
Volume1,256,551
Average volume (3 months)4,328,330
Market cap--
Dividend yield--
Data as of 11:46am ET, 07/23/2014

Growth & Valuation

Earnings growth (last year)+44.44%
Earnings growth (this year)+17.33%
Earnings growth (next 5 years)--
Revenue growth (last year)-52.64%
P/E ratioNM
Price/Sales474.30
Price/Book--

Competitors

 Today’s
change
Today’s
% change
AMAGAMAG Pharmaceuticals...+0.46+2.49%
DNDNDendreon Corp+0.02+0.97%
VCYTVeracyte Inc+0.29+2.04%
GALTGalectin Therapeutic...-0.10-0.74%
Data as of 11:47am ET, 07/23/2014

Financials

Next reporting dateJuly 31, 2014
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$1.3M
Annual profit (last year)-$38.4M
Net profit margin-2,991.35%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John A. Scarlett
Chief Financial Officer, Treasurer &
Executive VP
Olivia K. Bloom
Corporate headquarters
Menlo Park, California

Forecasts